Your browser doesn't support javascript.
loading
Exceptional response to nivolumab of a heavily pre-treated patient with metastatic renal-cell cancer: from a case report to molecular investigation and future perspectives.
Dimitrakopoulos, Foteinos-Ioannis D; Kourea, Eleni; Nasioulas, George; Papadopoulou, Eirini; Nikolakopoulos, Achilles; Spyropoulou, Despoina; Kottorou, Anastasia; Karatzas, Andreas; Kalofonos, Haralabos P; Koutras, Angelos.
Afiliación
  • Dimitrakopoulos FD; Department of Medicine, Medical School, Division of Oncology, University of Patras, Rion-Patras, 26504, Greece.
  • Kourea E; Department of Pathology, School of Medicine, University of Patras, Patras, Greece.
  • Nasioulas G; GeneKor Medical SA, Athens, Greece.
  • Papadopoulou E; GeneKor Medical SA, Athens, Greece.
  • Nikolakopoulos A; Department of Medicine, Medical School, Division of Oncology, University of Patras, Patras, Greece.
  • Spyropoulou D; Department of Radiation Oncology, Medical School, University of Patras, Patras, Greece.
  • Kottorou A; Department of Medicine, Medical School, Division of Oncology, University of Patras, Patras, Greece.
  • Karatzas A; Department of Radiology, Olympion Therapeutirio, Patras, Greece.
  • Kalofonos HP; Department of Medicine, Medical School, Division of Oncology, University of Patras, Patras, Greece.
  • Koutras A; Department of Medicine, Medical School, Division of Oncology, University of Patras, Rion-Patras, 26504, Greece.
Ther Adv Med Oncol ; 12: 1758835920946152, 2020.
Article en En | MEDLINE | ID: mdl-32849917

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2020 Tipo del documento: Article País de afiliación: Grecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ther Adv Med Oncol Año: 2020 Tipo del documento: Article País de afiliación: Grecia
...